ADTX

Aditxt, Inc.

0.3485

Top Statistics
Market Cap 4 M Forward PE -0.0309 Revenue Growth -80.00 %
Current Ratio 0.07 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.2340 Enterprise / Revenue 23.53 Price To Sales Trailing12 Months 15.04
Profitability
Profit Margins 0.00 % Operating Margins -13497.11 %
Balance Sheet
Total Cash 91223 Total Cash Per Share 1.01 Total Debt 8 M
Total Debt To Equity 126.76 Current Ratio 0.07 Book Value Per Share 486.95
All Measures
Short Ratio 16.00 % Message Board Id finmb_551021594 Shares Short Prior Month 5748
Return On Equity -34.94 City Richmond Uuid f1a690cd-ba99-37b7-a57e-7f10c4ee72bb
Previous Close 0.3299 First Trade Date Epoch Utc 1 B Book Value 486.95
Beta 1.08 Total Debt 8 M Volume 645709
Price To Book 0.0007 Last Split Date 1 B Fifty Two Week Low 0.3100
Total Cash Per Share 1.01 Total Revenue 329739 Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -13497.11 %
Net Income To Common -43313332 Short Percent Of Float 0.1042 Implied Shares Outstanding 14 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M
Average Volume10days 1 M Total Cash 91223 Next Fiscal Year End 1 B
Revenue Per Share 12.11 Held Percent Insiders 0.0001 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.3299
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.33
Open 0.3299 Free Cashflow -13256582 State VA
Dividend Yield 0.00 % Return On Assets -1.18 Time Zone Short Name EST
Trailing Eps -22893.75 Day Low 0.3260 Address1 737 North Fifth Street
Shares Outstanding 14 M Price Hint 4 Target High Price 0.0000
Website https://www.aditxt.com 52 Week Change -0.9978 Average Volume 2 M
Forward Eps -11.29 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 2.40 % Last Split Factor 1:40 Regular Market Day High 0.3550
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 126.76
Fifty Two Week High 380.00 Day High 0.3550 Shares Short 910844
Regular Market Open 0.3299 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 23.53 Revenue Growth -80.00 % Shares Percent Shares Out 0.1042
Operating Cashflow -19594000 Currency USD Time Zone Full Name America/New_York
Market Cap 4 M Is_nasdaq_100 False Zip 23219
Quote Type EQUITY Industry Biotechnology Long Name Aditxt, Inc.
Regular Market Day Low 0.3260 Held Percent Institutions 0.0025 Current Price 0.3485
Address2 Suite 200 Enterprise To Ebitda -0.2340 Financial Currency USD
Current Ratio 0.07 Gross Margins -46.09 % Industry Disp Biotechnology
Country United States Float Shares 89886 Two Hundred Day Average 62.20
Enterprise Value 7 M Price To Sales Trailing12 Months 15.04 Forward PE -0.0309
Regular Market Volume 645709 Ebitda -33094198 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems.

The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.

It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis.

Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University.

The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021.

Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.